CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Core Laboratories Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
Core Laboratories Inc. /DE/ revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reservoir Description [Member] | $78.75M | $81.93M | $92.28M | $88.22M | $86.28M | $80.90M | $86.79M | $88.84M | $86.28M | $84.24M | $84.63M | $85.15M | 63.2% | -8.7% |
| Production Enhancement [Member] | $45.86M | $39.87M | $45.97M | $46.30M | $43.88M | $42.69M | $42.44M | $45.56M | $44.30M | $45.40M | $43.58M | $40.20M | 36.8% | +4.5% |
| Corporate and Other [Member] | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Production Enhancement [Member] | $5.23M | $804.00K | $3.03M | $4.38M | $3.15M | $1.50M | -$2.60M | $3.23M | $4.40M | $1.58M | $2.20M | $1.54M | +66.1% |
| Reservoir Description [Member] | $3.68M | $1.15M | $12.82M | $16.57M | $12.20M | $2.34M | $16.64M | $16.49M | $11.44M | $6.89M | $12.26M | $12.99M | -69.9% |
| Corporate and Other [Member] | $245.00K | -$63.00K | -$16.00K | -$25.00K | -$60.00K | $575.00K | $128.00K | $84.00K | $164.00K | $103.00K | $127.00K | $136.00K | -508.3% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service [Member] | $94.28M | $94.25M | $106.99M | $101.13M | $96.22M | $95.09M | $96.53M | $98.84M | $96.34M | $96.50M | $94.69M | $92.88M | 75.7% | -2.0% |
| Product [Member] | $30.33M | $27.55M | $31.27M | $33.40M | $33.94M | $28.49M | $32.71M | $35.56M | $34.24M | $33.14M | $33.52M | $32.46M | 24.3% | -10.6% |
By region
From the segment and revenue-disaggregation notes of Core Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.